Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sucrosofate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 6/20 | 0.74 |
| ▸ | FGF2 | P09038 | 4/20 | 0.74 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.36 |
| ▸ | HPSE | Q9Y251 | 13/20 | 0.36 |
| ▸ | VEGFA | P15692 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sucrosofate SCHEMBL18467935 | 1.00 | FGF1 (0.74) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL145069 | 1.00 | FGF1 (0.74) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL16661862 | 1.00 | FGF1 (0.74) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL16661861 | 1.00 | FGF1 (0.74) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL18742107 | 0.99 | FGF1 (0.72) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL921799 | 0.99 | FGF1 (0.72) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL18244210 | 0.93 | FGF1 (0.65) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL19358882 | 0.93 | FGF1 (0.65) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Sucrosofate SCHEMBL2063889 | 0.93 | FGF1 (0.65) | FGF1FGF2SERPINC1HPSEVEGFA | |
| Water SCHEMBL41379 | 0.90 | FGF1 (0.61) | FGF1FGF2SERPINC1HPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2275 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743090-A1 | LIPOSOME ENCAPSULATED APOMORPHINE | Liposome Holdings Limited (NZ) | 2026-05-20 | — | — | EP | claimed |
| US-12629387-B2 | Composition of antiviral agent for use in prophylactic or post-exposure treatment of infectious or respiratory diseases | INSPIRMED CORP. (TW) | 2026-05-19 | — | — | US | claimed |
| US-12629354-B2 | Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof | TAIWAN LIPOSOME CO., LTD. (TW) | 2026-05-19 | — | — | US | claimed |
| US-20260108534-A1 | LIPOSOMAL FORMULATIONS OF BCL INHIBITORS | JAZZ PHARMACEUTICALS THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| US-12599557-B2 | Liposomal sustained-release compositions containing a therapeutic drug and use thereof | TLC BIOPHARMACEUTICALS, INC. (US) | 2026-04-14 | — | — | US | claimed |
| EP-4410370-B1 | COMPOSITIONS FOR PROMOTING THE HEALING OF WOUNDS | REPONEX PHARMACEUTICALS AS (DK) | 2026-03-18 | — | — | EP | claimed |
| EP-4709393-A1 | USE OF OLIGOSACCHARIDE COMPOUNDS FOR PREVENTING THE RECURRENCE OF NEURO-ISCHEMIC WOUNDS IN DIABETIC PATIENTS | URGO RECHERCHE INNOVATION ET DEVELOPPEMENT (FR) | 2026-03-18 | — | — | EP | claimed |
| US-20260069538-A1 | CXCR4 ANTAGONIST LOADED LIPOSOMES AND SILICASOMES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-03-12 | — | — | US | claimed |
| CN-121570423-A | Multi-flexbile ratio Star and cyclophosphates amide liposome compound injection | 山西普德药业有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-12539338-B2 | Nano-enabled immunotherapy in cancer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-03 | — | — | US | claimed |
| CN-1049608-A | The method of treatment tooth and supporting tissue illness thereof | BUKH MEDITEC (DK) | 1991-03-06 | — | — | CN | claimed |
| US-4990610-A | Reacting Sucrose with Chlorosulfonic acid and 2-Picoline | APPLIED ANALYTICAL INDUSTRIES, INC. (US) | 1991-02-05 | — | — | US | claimed |
| WO-1990012561-A1 | COSMETIC COMPOSITION | BUKH MEDITEC A/S (NIELS BUKH A/S) (DK) | 1990-11-01 | — | — | WO | claimed |
| EP-0394333-A1 | USES OF SULPHATED SUGARS. | BUKH MEDITEC (DK) | 1990-10-31 | — | — | EP | claimed |
| US-4948883-A | Preparation of hydrogen and bismuth (phosph/sulf) ated saccharides | MARION LABORATORIES, INC. (US) | 1990-08-14 | — | — | US | claimed |
| US-4935406-A | Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders | MARION LABORATORIES, INC. (US) | 1990-06-19 | — | — | US | claimed |
| US-4912093-A | Polysulfated (mono- or oligo-)saccharide | MARION LABORATORIES, INC. (US) | 1990-03-27 | — | — | US | claimed |
| WO-1989005646-A1 | USES OF SULPHATED SUGARS | BUKH MEDITEC A/S (DK) | 1989-06-29 | — | — | WO | claimed |
| CN-88102143-A | Stable basic sucralfate aluminum sulfate suspension pharmaceutical composition without suspending agent | — | 1988-12-28 | — | — | CN | claimed |
| EP-0230023-A2 | Pharmaceutical compositions for the enhancement of wound healing | MARION MERRELL DOW INC. (US) | 1987-07-29 | — | — | EP | claimed |